Crossmark

Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia

Crossref DOI link: https://doi.org/10.1007/s13311-019-00797-2

Published Print: 2019-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Jiang, Jie https://orcid.org/0000-0001-9519-4992
Ravits, John
Funding

Funding for this research was provided by:

Target ALS (20134792)

Amyotrophic Lateral Sclerosis Association (5356S3)

National Institute of Neurological Disorders and Stroke (R01NS088578)

National Institute of Neurological Disorders and Stroke (NS047101)

Muscular Dystrophy Association (479769)
License Information

Text and Data Mining valid from 2019-10-01

Text and Data Mining valid from 2019-10-01

Version of Record valid from 2023-08-22
More Information

This article is maintained by: Elsevier

Article Title: Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-019-00797-2

Content Type: article

Copyright: Copyright © 2019 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.